Assessment of Endogenous Thyroid Hormone Production
The most reliable method to assess endogenous thyroid hormone production is through measurement of serum TSH, free T4, and free T3 levels, with TSH being the primary screening test due to its high sensitivity and specificity. 1
Primary Diagnostic Tests
First-Line Testing
- Thyroid Stimulating Hormone (TSH):
Second-Line Testing (if TSH is abnormal)
- Free T4 (FT4): Measures unbound thyroxine, not affected by binding protein variations
- Free T3 (FT3) or Total T3: Particularly important when hyperthyroidism is suspected 2, 1
- Anti-thyroid antibodies: To identify autoimmune thyroid disease 1
- Anti-peroxidase antibodies (TPO-Ab)
- TSH receptor antibodies (TRAb)
Interpretation of Results
Normal Thyroid Function
- TSH: 0.45-4.5 mIU/L (reference ranges may vary by laboratory)
- Free T4: Within normal range
- Free T3: Within normal range
Patterns Indicating Thyroid Dysfunction
Primary Hypothyroidism:
- Elevated TSH with low or low-normal free T4
- May require treatment with levothyroxine 3
Primary Hyperthyroidism:
- Suppressed TSH (<0.1 mIU/L) with elevated free T4 and/or free T3
- Requires further evaluation with radioactive iodine uptake to distinguish between causes 2
Subclinical Hypothyroidism:
- Elevated TSH with normal free T4
- May progress to overt hypothyroidism 2
Subclinical Hyperthyroidism:
- Suppressed TSH with normal free T4 and free T3
- Two categories: mildly low but detectable TSH (0.1-0.45 mIU/L) and clearly low TSH (<0.1 mIU/L) 2
Central (Secondary/Tertiary) Hypothyroidism:
- Low or inappropriately normal TSH with low free T4
- Requires monitoring of free T4 levels rather than TSH 3
Additional Testing for Specific Situations
For Suspected Hyperthyroidism with Low TSH
- Radioactive iodine uptake and scan: Distinguishes between destructive thyroiditis and hyperthyroidism due to Graves' disease or nodular goiter 2
- TSH receptor antibodies (TRAb): Positive in Graves' disease 1
For Discrepancies Between TSH and Free Thyroid Hormones
- Consider thyroid hormone autoantibodies (THAA) or heterophilic antimouse antibodies (HAMA) that can interfere with assays 4
- Ultrafiltration liquid chromatography-tandem mass spectrometry (LC-MS/MS) may provide more accurate measurement in cases where immunoassays give questionable results 5
Follow-up Testing Protocol
For abnormal initial TSH:
For subclinical hyperthyroidism:
- If TSH is between 0.1-0.45 mIU/L: Repeat testing in 3 months
- If TSH is <0.1 mIU/L: Repeat testing within 4 weeks with free T4 and free T3 2
For treated hypothyroidism:
- Monitor TSH and free T4 4-6 weeks after initiating or changing levothyroxine dosage
- Once stable, evaluate every 6-12 months 3
Common Pitfalls to Avoid
Relying on a single TSH value: TSH can vary by up to 50% on a day-to-day basis 2
Ignoring non-thyroidal factors affecting TSH:
Misinterpreting results in elderly patients:
Overlooking euthyroid sick syndrome:
- Characterized by low T3 with normal TSH, T4, and free T4 levels
- An adaptive response to chronic disease rather than thyroid gland dysfunction 1
Simultaneous TSH and free T4 testing in all cases:
- The two-step approach (measuring TSH first, then free T4 only if TSH is abnormal) is more cost-effective
- This approach may avoid measuring free T4 in as many as 93% of individuals with minimal risk of missing thyroid dysfunction 7
By following this systematic approach to assessing endogenous thyroid hormone production, clinicians can accurately diagnose thyroid dysfunction and monitor treatment efficacy while avoiding common diagnostic pitfalls.